11111

11111

ACERCA DEL EVENTO

Welcome to the 4th Global Conference for World Pneumonia Day 2024

Queridos colegas, amigos y público general

As Chairpersons of the 4th Global Conference for World Pneumonia Day 2024 it gives us great pleasure to invite you to join our event which is part of the Worldwide Pneumonia Awareness Campaign-Pneumolight, with the support of the Philippine College of Physicians (PCP) in Manila, to be held on 9 November 2024.

Despite the global impact of the COVID-19 pandemic, pneumonia remains a neglected disease. Sadly, the 2021 Global Burden of Disease report showed that 2.1 million people died of pneumonia in that year; children under five years and adults over 70 continued to be the most vulnerable populations, with more than 500,000 and 1 million pneumonia-related deaths respectively. Another important problem is the impact of antimicrobial resistance (AMR); according to the 2019 GBD report, 1.27 million deaths were attributable to bacterial AMR in that year, and one in five deaths caused by AMR occurred in children under five years old. The 2019 GBD report identified Streptococcus pneumoniae as the most frequent pathogen causing pneumonia, contributing to 16% of the deaths attributable to AMR.

¿Donde?

Manila, Philippines

¿Cuando?

November 09, 2024

11111

ACERCA DEL EVENTO

Bienvenidos a la 3.a Conferencia Global por el Día Mundial de la Neumonía

Queridos colegas, amigos y público general

Es un gran placer -como Presidenta de la Conferencia Global- darles la bienvenida a la 3.a Conferencia Global por el Día Mundial de la Neumonía, que tendrá lugar el 10 de noviembre del 2023 en Lima, Perú.

La neumonía es la mayor causa de muerte infecciosa en el mundo, solo en el año 2019 cobró 2,5 millones de vidas, incluidos 672.000 niños menores de cinco años. Eso equivale a que muere una persona cada 13 segundos. No obstante, la neumonía continua siendo una enfermedad desatendida. La pandemia por la enfermedad del coronavirus (covid-19) ha puesto, claramente, las enfermedades del tracto respiratorio en el centro de la salud pública. En el año 2021, la carga estimada de muertes por infecciones respiratorias, incluyendo la covid-19, fue la masiva cifra de 6 millones.

¿Donde?

Lima, Peru and Virtually

¿Cuando?

Noviembre 10, 2023 13:00

11111

Grandes conferencistas

Ponentes de múltiples partes del mundo reunidos en un solo lugar

Experiencia

Ponentes con amplia experiencia y un programa académico relevante

Red de trabajo

Contacto con cientos de colegas especializados en diferentes áreas de la salud

Asistencia

Desde cualquier parte del mundo, solo necesitas un dispositivo y conexión a internet

11111

Modern Marketing
Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea commodo consequat

COMITÉ ORGANIZADOR

Catia Cillóniz

Coordinator of the Worldwide Pneumonia Awareness Campaing

Guinevere Dy Agra

PCCP Council Chair, Health Informatics and Social Media

Rodolfo S. Pagcatipunan Jr

Vice-President, Research and Biotechnology, St. Luke’s Medical Center

11111

11111

CONTÁCTENOS

Dirección del salón de eventos

  • Hora
  • Gratis

Noviembre 10, 2023

13:00 - 16:30
Centro de Convenciones del Colegio Médico del Peru
Av. 28 de julio, 776, Miraflores

This event is a free, join us from anywhere in the world

How to get there

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt labore et dolore magna aliqua. Aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore.

11111

REDUCIR LA CARGA DE LA NEUMONÍA EN LAS AMÉRICAS

3.a Conferencia Global por
el Día Mundial de la Neumonía

Dear Colleagues & Friends,

As Chairpersons of the 4th Global Conference for World Pneumonia Day 2024, it gives us great pleasure to invite you to join our event, which is part of the Worldwide Pneumonia Awareness Campaign-Pneumolight, with the support of the Philippine College of Physicians (PCP) in Manila, to be held on 9 November 2024.

Despite the global impact of the COVID-19 pandemic, pneumonia remains a neglected disease. Sadly, the 2021 Global Burden of Disease report showed that 2.1 million people died of pneumonia in that year; children under five years and adults over 70 continued to be the most vulnerable populations, with more than 500,000 and 1 million pneumonia-related deaths respectively. Another important problem is the impact of antimicrobial resistance (AMR); according to the 2019 GBD report, 1.27 million deaths were attributable to bacterial AMR in that year, and one in five deaths caused by AMR occurred in children under five years old. The 2019 GBD report identified Streptococcus pneumoniae as the most frequent pathogen causing pneumonia,
contributing to 16% of the deaths attributable to AMR.

Although great progress continues to be made, the worldwide burden of pneumonia remains huge. We need everyone to know about the disease and its impact on our health, and above all, we need to show that it can be prevented. Pneumonia must be recognized as a major global health problem. Until this recognition comes, we will continue our attempts to educate and prevent, because we know that education is prevention and prevention saves lives.

Working together, we can move the world because we know that if we fight, we can win!!!!

Yours sincerely,

Catia Cilloniz
Guinevere Dy-Agra
Rodolfo S. Pagcatipunan Jr

This will close in 0 seconds

This will close in 0 seconds

This will close in 0 seconds

Louis Bont, MD, PhD


Louis Bont, MD, PhD, is a Pediatric Infectiologist-Immunologist and the head of the Pediatric Department at the University Medical Center Utrecht, The Netherlands. He is the founding chairman of ReSViNET, an international respiratory syncytial virus (RSV) research consortium. His specific research interests include RSV pathogenesis and the burden of disease.

Dr. Bont's work focuses on unraveling the role of neutrophils, RSV-related mortality, and long-term airway disease following RSV infection. He is the lead investigator of the INFORM study, a large prospective global clinical virology study that aims to uncover the molecular epidemiology of RSV in over 2000 children. He also leads the RSV GOLD mortality registry, funded by the Bill and Melinda Gates Foundation.

His group collaborates with the World Health Organization on RSV surveillance and vaccine development. Dr. Bont’s research emphasizes clinical and translational mechanisms of disease and the identification of intervention targets for RSV bronchiolitis. He has been the lead author of over 300 publications in peer-reviewed medical journals.

Additionally, he founded the Training of Upcoming Leaders in Pediatric Science (TULIPS), a career training network for clinician scientists in the field of Child Health.

This will close in 0 seconds

This will close in 0 seconds